Announcements Trials
Browse Landscape

Phase

Phase 3 2

Status

Terminated 1Completed 1

Sponsor Class

OTHER 2NETWORK 2NIH 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 2Breast 1

Conditions

Breast Neoplasms 29Breast Carcinoma In Situ 4Carcinoma, Intraductal, Noninfiltrating 3Endometrial Neoplasms 2Carcinoma, Ductal, Breast 2Breast Neoplasms, Male 2Sleep Wake Disorders 1Paget's Disease, Mammary 1Gliosarcoma 1Glioblastoma 1Fatigue 1Desmoid Tumors 1Central Nervous System Neoplasms 1Carcinoma, Lobular 1Advanced, Persistent, or Recurrent Endometrial Cancer 1

Interventions

Paclitaxel 8Doxorubicin 7Cisplatin 7Radiotherapy 4Filgrastim 4Chemotherapy, Adjuvant 3Tamoxifen 2Radiotherapy, Intensity-Modulated 2Observation 2Medroxyprogesterone 2Letrozole 2Ifosfamide 2Gene Expression Profiling 2Carboplatin 2Amifostine 2ridaforolimus 1perifosine 1lenvatinib 1irofulven 1abemaciclib 1X-Rays 1Trabectedin 1Therapeutics 1Taxes 1Surgical Procedures, Operative 1Specimen Handling 1Radiotherapy, Adjuvant 1Polymerase Chain Reaction 1Phantoms, Imaging 1Pemetrexed 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
NETWORK × Endometrial Neoplasms × Tamoxifen × Clear all
NCT00016341 2013-04-11

Combination Chemotherapy Compared With Hormone Therapy in Treating Patients With Recurrent, Stage III, or Stage IV Endometrial Cancer

GOG Foundation

Phase 3 Terminated
Gynecologic

Endometrial Neoplasms

NCT00002920 2012-10-31

S9630, Medroxyprogesterone in Treating Women With Breast Cancer

SWOG Cancer Research Network

Phase 3 Completed
313 enrolled
BreastGynecologic

Breast Carcinoma In Situ, Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating, Paget's Disease, Mammary, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡